Imunon Inc (IMNN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,196 | -11,786 | 35,349 | -7,584 | -8,685 |
| Depreciation Amortization | -936 | -2,355 | -139 | -341 | -321 |
| Accounts receivable | N/A | N/A | 1,699 | -1,202 | -24 |
| Other Working Capital | 15,056 | 14,400 | 1,640 | 524 | 751 |
| Other Operating Activity | 146 | 2,022 | -48,132 | 1,370 | 217 |
| Operating Cash Flow | $-930 | $2,281 | $-9,583 | $-7,233 | $-8,062 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,566 | -1,061 | 5,000 | -2,000 | 3,900 |
| PPE Investments | -136 | -24 | 9,868 | -188 | -109 |
| Sale Of Investment | N/A | N/A | N/A | -197 | N/A |
| Purchase Sale Intangibles | N/A | N/A | -1,600 | -75 | N/A |
| Other Investing Activity | 0 | 0 | -1,655 | -661 | 0 |
| Investing Cash Flow | $-1,702 | $-1,086 | $13,212 | $-3,046 | $3,792 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 1,182 | 9,000 | 6,000 |
| Debt Repayment | -235 | -677 | -270 | N/A | N/A |
| Common Stock Issued | 6,335 | N/A | 3 | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | -2,639 | -2 | N/A |
| Financing Cash Flow | $6,100 | $-677 | $-1,725 | $8,998 | $6,000 |
| Beginning Cash Position | 3,456 | 2,937 | 1,033 | 2,313 | 583 |
| End Cash Position | 6,924 | 3,456 | 2,937 | 1,033 | 2,313 |
| Net Cash Flow | $3,467 | $519 | $1,905 | $-1,281 | $1,730 |
| Free Cash Flow | |||||
| Operating Cash Flow | -930 | 2,281 | -9,583 | -7,233 | -8,062 |
| Capital Expenditure | -136 | -24 | -91 | -188 | -109 |
| Free Cash Flow | -1,067 | 2,257 | -9,674 | -7,421 | -8,170 |